Just waiting for one of those potential rocket news events, there are some upcoming events which could start something moving.
Recent THAR News
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 03/11/2024 08:30:08 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/11/2024 08:15:32 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 02/23/2024 01:30:52 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/08/2024 09:05:29 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/12/2023 09:15:16 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 12/11/2023 11:15:17 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/27/2023 09:05:44 PM
- Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses • Edgar (US Regulatory) • 11/17/2023 10:24:16 PM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 11/17/2023 09:22:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/17/2023 09:05:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/16/2023 09:05:31 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/10/2023 12:55:53 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/10/2023 12:52:28 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/07/2023 10:02:23 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/07/2023 09:10:40 PM
- Form DEL AM - Delaying amendment • Edgar (US Regulatory) • 11/07/2023 05:29:12 PM
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 11/06/2023 10:12:14 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 11/02/2023 08:05:53 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2023 08:15:11 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 09/29/2023 08:05:09 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM